Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amylin and Biocon say they will work together to develop diabetes drug combining 2 hormones
Yahoo/AP
Friday, September 11, 2009 - 8:23am
tags:
Amylin, Biocon, partnerships, diabetes
Shire Set for $50 Million Windfall on Demand for Gaucher Drug
Bloomberg
Friday, September 11, 2009 - 8:21am
tags:
Shire, Genzyme, Gaucher disease
Vivus: A One Trick Pony
Seeking Alpha
Friday, September 11, 2009 - 8:19am
tags:
Vivus, Arena Pharmaceuticals, Orexigen, obesity, Qnexa
Eli Lilly cites reduction in chronic lower back pain in Cymbalta study
Yahoo/AP
Friday, September 11, 2009 - 8:19am
tags:
Eli Lilly, Cymbalta, back pain, chronic pain
Another Positive Indication for Amgen's Denosumab
Seeking Alpha
Friday, September 11, 2009 - 6:01am
tags:
Amgen, denosumab, Novartis, rheumatoid arthritis
GlaxoSmithKline to Defend Paxil in Birth Defect Test-Case Trial
Bloomberg
Friday, September 11, 2009 - 6:00am
tags:
GSK, antidepressants, Paxil, lawsuits, birth defects
Glaxo's U.S. Cervarix Approval More Important for Company's Pride than for Sales
Seeking Alpha
Friday, September 11, 2009 - 5:59am
tags:
GSK, Cervarix, Merck, Gardasil, HPV, vaccines
Swine Flu Update: A Single-Dose Vaccine Appears to Work, Study Shows
WSJ Online
Thursday, September 10, 2009 - 9:15pm
tags:
swine flu, H1N1, vaccines, CSL, Novartis
Abbott Labs Buys Device Maker
WSJ Online
Thursday, September 10, 2009 - 5:49pm
tags:
Abbott Laboratories, medical devices, Evalve, M&A
The Vanishing Vaccine War
Motley Fool
Thursday, September 10, 2009 - 5:47pm
tags:
vaccines, Merck, GSK, HPV, Cervarix, Gardasil
FDA wants more data about Johnson & Johnson's ovarian cancer drug Yondelis
Yahoo/AP
Thursday, September 10, 2009 - 5:46pm
tags:
FDA, JNJ, Yondelis, ovarian cancer
Glaxo Moves Ahead With Cervarix
Yahoo/Zacks.com
Thursday, September 10, 2009 - 3:23pm
tags:
GSK, vaccines, Cervarix, HPV
Pfizer rated 'Overweight' on late stage pipeline
Yahoo/AP
Thursday, September 10, 2009 - 3:21pm
tags:
Pfizer, pipelines, Wyeth, bapineuzumab, Sutent, Prevnar 13
Goldman Sachs on Healthcare: ‘A Stock Picker’s Paradise’
WSJ Online
Thursday, September 10, 2009 - 3:20pm
tags:
drug stocks
Pharma shares flat a day after Obama speech reaffirms push for health care reform
Yahoo/AP
Thursday, September 10, 2009 - 3:19pm
tags:
drug stocks, Obama, healthcare reform
MS drug Tysabri reawakens brain virus -study
Forbes/Reuters
Thursday, September 10, 2009 - 11:31am
tags:
MS, Tysabri, Elan, Biogen Idec, PML, multiple sclerosis
Boehringer Ingelheim likely to have regulatory submission for Pradaxa delayed
FT.com
Thursday, September 10, 2009 - 11:26am
tags:
Boehringer Ingelheim, Pradaxa
Generic drugmaker stocks unaffected following Obama address on health care reform plans
Yahoo/AP
Thursday, September 10, 2009 - 11:24am
tags:
healthcare reform, generics, Mylan, Forest Labs
Merck ends development of an experimental migraine treatment, cites potential liver problems
Yahoo/AP
Thursday, September 10, 2009 - 11:02am
tags:
Merck, migraines
Top Facet Investor's Big Sell-Off
InVivo
Thursday, September 10, 2009 - 10:44am
tags:
Facet Biotech, M&A, Biogen Idec

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.